Pharmacokinetic and pharmacodynamic interactions between metformin and a novel dipeptidyl peptidase-4 inhibitor, evogliptin, in healthy subjects

Pharmacokinetic and pharmacodynamic interactions between metformin and a novel dipeptidyl peptidase-4 inhibitor, evogliptin, in healthy subjects

Su-jin Rhee,1,* YoonJung Choi,1,* SeungHwan Lee,1,2 Jaeseong Oh,1 Sung-Jin Kim,3 Seo Hyun Yoon,1 Joo-Youn Cho,1 Kyung-Sang Yu1 1Department of Clinical Pharmacology and Therapeutics, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea; 2Clinical...

Full description

Bibliographic Details
Main Authors: Rhee SJ, Choi Y, Lee S, Oh J, Kim SJ, Yoon SH, Cho JY, Yu KS
Format: Article
Language:English
Published: Dove Medical Press 2016-08-01
Series:Drug Design, Development and Therapy
Subjects:
drug-drug interactions
evogliptin
metformin IR
pharmacokinetics
pharmacodynamics
DA-1229
Online Access:https://www.dovepress.com/pharmacokinetic-and-pharmacodynamic-interactions-between-metformin-and-peer-reviewed-article-DDDT

Internet

https://www.dovepress.com/pharmacokinetic-and-pharmacodynamic-interactions-between-metformin-and-peer-reviewed-article-DDDT

Similar Items